Mercury Antibiotics Private Limited
About Mercury Antibiotics Private Limited
Data last updated:
Mercury Antibiotics Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 August 1989.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH1989PTC137079. Its GSTIN is 24AABCM2837P1Z7 (Gujarat).
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹23.44 Lakh. It was led by directors including Kaumudini Rajendra Shah (Whole-Time Director) and Dilip Ramanlal Shah.
Its last annual general meeting (AGM) was held on 26 August 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 18 Shreeji Bhuvan Mangaldas Road Princess Street 1, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2022, the company reported a revenue of ₹51.88 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹25.66 Lakh (net margin 49.5%) and EBITDA of -₹17.69 Lakh (EBITDA margin -34.1%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 3% over five years.
As per MCA filings, the company has satisfied charges of ₹8.86 Cr on record. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 1 case is pending.
Company details
CIN history
Mercury Antibiotics has one previous CIN (Corporate Identification Number): U24231MH2002PTC137079. The current CIN is U24231MH1989PTC137079, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH1989PTC137079 | Current |
| U24231MH2002PTC137079 | Previous |
Contact details
Mercury Antibiotics Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address18 Shreeji Bhuvan Mangaldas Road Princess Street 1, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mercury Antibiotics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mercury Antibiotics Private Limited
FY 2022 filings availableMercury Antibiotics Private Limited reported revenue of ₹51.88 Lakh (down 10% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 10% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹51.88 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹17.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34.1% | ||||
| Net Profit Margin | 49.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mercury Antibiotics Private Limited, buy the company report.
Board of directors of Mercury Antibiotics Private Limited
Mercury Antibiotics has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaumudini Rajendra Shah Also directs: Mercury Antibiotics LLP | Whole-Time Director | 04 Oct 1997 | 29 Years 1 Months | As last reported |
| Dilip Ramanlal Shah Also directs: Mercury Laboratories Limited | Director | 01 Sep 1998 | 28 Years 2 Months | As last reported |
| Rajendrakumar Ramanlal Shah Also directs: Mercury Laboratories Limited | Director | 18 Aug 2005 | 21 Years 2 Months | As last reported |
Auditor
Mercury Antibiotics Private Limited is audited by PARIKH SHAH CHOTALIA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARIKH SHAH CHOTALIA & ASSOCIATES | FY 2019 | 118493W |
Shareholding
The shareholding of Mercury Antibiotics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Mercury Antibiotics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Sep 2011 | 10309097 | Others | ₹8.31 Cr | Satisfied | |
| 28 Jun 2010 | 10230645 | Small Industries Development Bank of India | ₹40 Lakh | Satisfied | |
| 16 Aug 2005 | 90351087 | State Bank of India | ₹15 Lakh | Satisfied |
To see the full charge records of Mercury Antibiotics Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Mercury Antibiotics Private Limited has 6 court cases on record: 3 filed by Mercury Antibiotics, 3 filed against it. 1 case is pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 1 | 1 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Court case (CRLP) | Filed by the company against The State of Telangana and 1 other | Pending |
| High Court, TELANGANA | Court case (CRLP) | Filed by the company against The State of Telangana | Disposed |
| District court, Mahabubnagar, Telangana | Court case (PRC) | Filed against the company by The State of Andhra Pradesh | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against Madhya Gujarat Vij Com.Ltd. Thro.Chief Officer, Baroda and 1 other | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Disposed |
To see the full case history of Mercury Antibiotics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mercury Antibiotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mercury Antibiotics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCM2837P1Z7 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mercury Antibiotics Private Limited, buy the company report.
Recent activity
Mercury Antibiotics Private Limited has 4 board changes on record since 1997: 3 appointments and 1 cessation. The latest: Kishoriben Dilip Shah ceased to be Director on 24 Jan 2019.
2 earlier events are in the company report.
Frequently asked questions
Mercury Antibiotics has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Mercury Antibiotics was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 23 August 1989 and is registered under CIN U24231MH1989PTC137079. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Mercury Antibiotics is U24231MH1989PTC137079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mercury Antibiotics had 3 directors:
- Kaumudini Rajendra Shah - Whole-Time Director
- Dilip Ramanlal Shah - Director
- Rajendrakumar Ramanlal Shah - Director
Mercury Antibiotics was incorporated on 23 August 1989. It is registered with the Registrar of Companies, Mumbai.
The registered office of Mercury Antibiotics is at 18 Shreeji Bhuvan Mangaldas Road Princess Street 1, Mumbai, Maharashtra, India – 400002.
The latest financial statements of Mercury Antibiotics on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 26 August 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Mercury Antibiotics is 24AABCM2837P1Z7, registered in Gujarat.
Mercury Antibiotics operated in the pharma industry, in the drug formulation and development segment.
Mercury Antibiotics has 6 court cases on record: 3 filed by the company and 3 filed against it. 1 is pending. Most are in the high courts.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
